Expertise in
9
conditions

Romain Lazor

Groupement Hospitalier Est, 
Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Groupement Hospitalier Est, 
Lyon, FR 

Overview

Romain Lazor practices practicing medicine in Lyon, France.

Mr. Lazor is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lymphangioleiomyomatosis, Birt-Hogg-Dube Syndrome, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Lung Transplant.

He is actively involved in clinical research, co-authoring 70 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Groupement Hospitalier Est, Lyon, France
Other Locations
Groupement Hospitalier Est, Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Multicentric Randomized Study on Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
Phase II Multicentric Randomized Study on Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
Enrollment Status: Recruiting
Publish Date: March 11, 2026
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Drug, Device
Study Phase: Phase 2
View 1 Less Clinical Trial

70 Total Publications

Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohort.
Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohort.
Journal: Pulmonology
Published: December 09, 2025

Frequently Asked Questions about Romain Lazor

Is Romain Lazor a top-rated expert for Lymphangioleiomyomatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Romain Lazor is classified as an Distinguished expert for Lymphangioleiomyomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Romain Lazor participate in research or clinical trials?

Yes. Romain Lazor has published 70 articles and abstracts on conditions like Lymphangioleiomyomatosis. You can view a list of Romain Lazor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lazor's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile